3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Neoplasms
10
Breast Neoplasms
9
Ovarian Neoplasms
8
Prostatic Neoplasms
7
Multiple Myeloma
6
Hematologic Neoplasms
6
Lung Neoplasms
5
Depression
5
Sleep Initiation and Maintenance Disorders
4
Motor Activity
4
Fatigue
4
Breast Carcinoma In Situ
4
Anxiety Disorders
4
Leukemia
3
Fallopian Tube Neoplasms
3
Endometrial Neoplasms
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Sleep Wake Disorders
2
Pancreatic Neoplasms
2
Pain
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Head and Neck Neoplasms
2
Interventions
Carboplatin
19
Pemetrexed
10
Paclitaxel
7
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
zipalertinib
2
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Docetaxel
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
spartalizumab
1
sotorasib
1
sitravatinib
1
sintilimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Diseases
×
Behavior Therapy
×
Clear all
NCT04630743
2020-11-16
CoBeMEB
University of Cologne
Phase NA
Completed
49 enrolled